Nadine A. M. E. van der Beek

A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease

Ans T. van der Ploeg, Paula R. Clemens, Deyanira Corzo et al. · New England Journal of Medicine · 2010 · 747 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +13

Modifying the Medical Research Council grading system through Rasch analyses

Els Karla Vanhoutte, Catharina G. Faber, Sonja I. van Nes et al. · Brain · 2011 · 248 citations · Full text

Health Professions, Neurology, Clinical Medicine +15

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 184 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +3

Broad spectrum of Pompe disease in patients with the same c.-32-13T→G haplotype

Marian A. Kroos, Robert J. Pomponio, M.L.C. Hagemans et al. · Neurology · 2007 · 175 citations

Life Sciences, Genetics, Molecular Genetics +16

Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study

Nadine A. M. E. van der Beek, Juna M. de Vries, M.L.C. Hagemans et al. · Orphanet Journal of Rare Diseases · 2012 · 141 citations · Full text

Medicine, Internal Medicine, Neurology +17